SRx Health enters waiver for new Series B preferred stock offering

SRx Health Solutions, Inc.

Existing investors waive participation rights and consent to Series B Preferred Stock ranking pari passu with Series A.
New offering of Series B Preferred Stock and related warrants planned under a new securities purchase agreement.
Waiver relates to prior July 2025 note financing and October 2025 Series A financing agreements.
Company must file Form 8-K disclosing material non-public information by next business day.
Effective date of waiver is upon receipt of identical agreements from other holders.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.